FDA Inspection 1001739 — Andrew Kao
The FDA completed an inspection of Andrew Kao on February 7, 2017 in Kansas City, MO. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Devices.
Inspection Details
- Classification
- No Action Indicated (NAI) (NAI)
- End Date
- February 7, 2017
- Fiscal Year
- 2017
- Product Type
- Devices
- Project Area
- Bioresearch Monitoring
- Location
- Kansas City, MO (United States)
Additional Details
Clinical Investigator (CI)